Duality Advisers, LP Iovance Biotherapeutics, Inc. Transaction History

Duality Advisers, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$4.44 - $8.79 $88,560 - $175,325	19,946 Added 81.68%	44,367 $201,000
Q2 2023 Jul 31, 2023	SELL	$5.36 - $9.06 $843,219 - $1.43 Million	-157,317 Reduced 86.56%	24,421 $171,000
Q1 2023 Jun 27, 2023	BUY	$5.53 - $8.22 $92,793 - $137,931	16,780 Added 10.17%	181,738 $1.11 Million
Q4 2022 Feb 07, 2023	BUY	$5.62 - $10.0 $320,435 - $570,170	57,017 Added 52.82%	164,958 $1.05 Million
Q3 2022 Nov 03, 2022	SELL	$9.53 - $13.11 $148,915 - $204,856	-15,626 Reduced 12.65%	107,941 $1.03 Million
Q2 2022 Aug 08, 2022	BUY	$6.38 - $18.33 $788,357 - $2.26 Million	123,567 New	123,567 $1.36 Million

318

244M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $963M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.